Beste apotheek van Nederland

study in 14 European countries. J Sex Med 2006
May;3(3):512-20.
248. von Keitz A, Stroberg P, Bukofzer S, et al. A
European multicentre study to evaluate the
tolerability of apomorphine sublingual
administered in a forced dose-escalation regimen
in patients with erectile dysfunction. BJU Int
2002 Mar;89(4):409-15.
249. Gontero P, D'Antonio R, Pretti G, et al. Clinical
efficacy of Apomorphine SL in erectile
dysfunction of diabetic men. Int J Impot Res
2005 Jan;17(1):80-5.
250. Hagemann JH, Berding G, Bergh S, et al. Effects
of visual sexual stimuli and apomorphine SL on
cerebral activity in men with erectile dysfunction.
Eur Urol 2003 Apr;43(4):412-20.
from a hemodynamic prospective study. J Urol
2003 Jun;169(6):2166-9.
257. Van der WF, Dohle GR, Van Der TJ, et al.
Intracavernosal injection therapy with and
without sexological counselling in men with
erectile dysfunction. BJU Int 2002
Jun;89(9):901-4.
258. Fu Q, Yao DH, Jiang YQ. A clinical comparative
study on effects of intracavernous injection of
sodium nitroprusside and
papaverine/phentolamine in erectile dysfunction
patients. Asian J Androl 2000 Dec;2(4):301-3.
259. Baum N, Randrup E, Junot D, et al.
Prostaglandin E1 versus sex therapy in the
management of psychogenic erectile dysfunction.
Int J Impot Res 2000 Jun;12(3):191-4.
251. Lammers PI, Rubio-Aurioles E, Castell R, et al. 260. Sandhu D, Curless E, Dean J, et al. A double
Combination therapy for erectile dysfunction: a
blind, placebo controlled study of intracavernosal
randomized, double blind, unblinded activecontrolled,
vasoactive intestinal polypeptide and
cross-over study of the
phenotolamine mesylate in a novel auto-injector
pharmacodynamics and safety of combined oral
for the treatment of non-psychogenic erectile
formulations of apomorphine hydrochloride,
dysfunction. Int J Impot Res 1999 Apr;11(2):91-
phentolamine mesylate and papaverine
7.
hydrochloride in men with moderate to severe
erectile dysfunction. Int J Impot Res
2002;14(1):54-9.
261.
252.
Dula E, Bukofzer S, Perdok R, et al. Doubleblind,
crossover comparison of 3 mg
apomorphine SL with placebo and with 4 mg
apomorphine SL in male erectile dysfunction.
Eur Urol 2001;39(5):558-3.
Dinsmore WW, Gingell C, Hackett G, et al.
Treating men with predominantly
nonpsychogenic erectile dysfunction with
intracavernosal vasoactive intestinal polypeptide
and phentolamine mesylate in a novel autoinjector
system: a multicentre double-blind
placebo-controlled study. BJU Int 1999
Feb;83(3):274-9.
253. Dula E, Keating W, Siami PF, et al. Efficacy and
safety of fixed-dose and dose-optimization
regimens of sublingual apomorphine versus
placebo in men with erectile dysfunction. The
Apomorphine Study Group. Urology 2000
Jul;56(1):130-5.
254. rruda-Olson AM, Pellikka PA. Appropriate use of
exercise testing prior to administration of drugs
for treatment of erectile dysfunction. [Review]
[47 refs]. Herz 2003 Jun;28(4):291-7.
255. Seyam R, Mohamed K, Akhras AA, et al. A
prospective randomized study to optimize the
dosage of trimix ingredients and compare its
efficacy and safety with prostaglandin E1. Int J
Impot Res 2005 Jul;17(4):346-53.
256. Gontero P, Fontana F, Bagnasacco A, et al. Is
there an optimal time for intracavernous
prostaglandin E1 rehabilitation following
nonnerve sparing radical prostatectomy? Results
262. Buvat J, Costa P, Morlier D, et al. Double-blind
multicenter study comparing alprostadil alphacyclodextrin
with moxisylyte chlorhydrate in
patients with chronic erectile dysfunction. J Urol
1998 Jan;159(1):116-9.
263. Montorsi F, Guazzoni G, Barbieri L, et al.
Genital plus audiovisual sexual stimulation
following intracavernous vasoactive injection
versus re-dosing for erectile dysfunction--results
of a prospective study. J Urol 1998
Jan;159(1):113-5.
264. Sogari PR, Teloken C, Souto CA. Atropine role
in the pharmacological erection test: study of 228
patients. J Urol 1997 Nov;158(5):1760-3.
265. Montorsi F, Guazzoni G, Strambi LF, et al.
Recovery of spontaneous erectile function after
nerve-sparing radical retropubic prostatectomy
with and without early intracavernous injections
of alprostadil: results of a prospective,
219